SLC35E1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.1401999979237E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.18220038997686E-10 |
Normal-vs-Stage2 |
2.195900E-03 |
Normal-vs-Stage3 |
3.944500E-03 |
Normal-vs-Stage4 |
1.228370E-02 |
Stage1-vs-Stage2 |
2.045000E-01 |
Stage1-vs-Stage3 |
5.941400E-03 |
Stage1-vs-Stage4 |
1.643780E-02 |
Stage2-vs-Stage3 |
4.577200E-01 |
Stage2-vs-Stage4 |
4.859600E-01 |
Stage3-vs-Stage4 |
9.864200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.03280000002459E-08 |
Normal-vs-AfricanAmerican |
7.557700E-02 |
Normal-vs-Asian |
1.733550E-01 |
Caucasian-vs-AfricanAmerican |
5.516200E-02 |
Caucasian-vs-Asian |
6.234400E-01 |
AfricanAmerican-vs-Asian |
7.887600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.68419999957825E-07 |
Normal-vs-Female |
3.6204999998013E-07 |
Male-vs-Female |
6.176200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.888400E-01 |
Normal-vs-Age(41-60Yrs) |
1.56320000055388E-07 |
Normal-vs-Age(61-80Yrs) |
4.12070000010978E-07 |
Normal-vs-Age(81-100Yrs) |
7.935900E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.873800E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.258400E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.229400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.472200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.984600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.652600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.38420000029127E-07 |
Normal-vs-Grade 2 |
3.88550003282973E-09 |
Normal-vs-Grade 3 |
3.8990000000072E-05 |
Normal-vs-Grade 4 |
2.504100E-02 |
Grade 1-vs-Grade 2 |
5.874400E-02 |
Grade 1-vs-Grade 3 |
2.884300E-02 |
Grade 1-vs-Grade 4 |
5.204700E-03 |
Grade 2-vs-Grade 3 |
1.031640E-01 |
Grade 2-vs-Grade 4 |
1.296150E-02 |
Grade 3-vs-Grade 4 |
2.739000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.9817480989559E-12 |
Normal-vs-ccB subtype |
4.237900E-03 |
ccA subtype-vs-ccB subtype |
1.29280000005227E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.43339999999037E-05 |
Normal-vs-N1 |
4.153800E-02 |
N0-vs-N1 |
4.095800E-01 |
|
|